CMO Letter to Reduce Unnecessary Antibiotic Prescribing March 2018

Prescribing, Off-Label Clinical Trial

Official title: Contacting GPs to Reduce Unnecessary Prescriptions of Antibiotics

Status Completed

Clinical Trial Summary

This trial aims to reduce unnecessary prescription of antibiotics by general practitioners (GPs) in England. Unnecessary prescriptions are defined as those that do not improve patient health outcomes. The intervention is to send GPs a letter from the Chief Medical Officer (CMO) that gives feedback on their practice's prescribing levels. Specifically, GPs in practices whose prescribing has increase by more than 4% over the past year will receive a letter stating that "The great majority (80%) of practices in England reduced or stabilised their antibiotic prescribing rates in 2016/17. However, your practice is in the minority that have increased their prescribing by more than 4%." The letter will also contain a leaflet to help GPs discuss self-care advice with patients and some advice to use delayed prescriptions. The investigators hypothesize that the antibiotic prescribing rate in will be lower for the treatment group compared to the control group, following the receipt of the letter.

Clinical Trial Description

The investigators hypothesize that the antibiotic prescribing rate in will be lower for the treatment group compared to the control group; the statistical analysis will compare prescribing in March, April, and over the summer (treating May-September as a single data point). ;

Related Conditions & MeSH terms

• Prescribing, Off-Label

• NCT number: NCT03582072
• Study type: Interventional
• Source: Public Health England
• Status: Completed
• Phase: N/A
• Start date: February 27, 2018
• Completion date: December 31, 2018